Dr. Robert M. Wachter, Chair of the Department of Medicine at the University of California, San Francisco, stated on 5 August 2022, that the United States healthcare system is significantly more expensive yet does not produce better outcomes than many Western countries.

In contrast, the National Health Service (NHS) in the United Kingdom is funded through general taxation, and its funding model has been a topic of discussion particularly in the wake of the COVID-19 pandemic. Analysis released on 20 July 2021 by the Office of National Statistics (ONS) revealed that NHS spending per capita was $3,500 in 2020, while the United States averaged $10,200.

This discrepancy raises questions about efficiency and the allocation of resources. A recent study from The Commonwealth Fund on 15 September 2022 showed that the UK outperformed the US in many health indicators, such as preventable deaths and life expectancy.

The German Model: A Middle Ground

Germany's healthcare system, characterized by its social health insurance model, operates on a principle of mandatory health insurance. According to a report by the World Health Organization on 29 July 2021, Germany spends approximately $6,400 per capita on healthcare. The German healthcare market’s efficiency lies in its competitive system, which is regulated by the state, ensuring access to care while providing patients with the choice of their providers.

However, the 2022 OECD Health Statistics revealed that Germany faces challenges regarding long waiting times for specialty care, an issue the US does not experience as acutely, albeit at a much higher cost. The presence of private health funds in Germany, which some patients opt for, often leads to a two-tiered system where affluent individuals can receive faster care.

Funding Dynamics in a Comparative Context

A telling aspect of these models is how each system finances itself and who benefits. In the US, the healthcare sector’s rise in spending primarily benefits pharmaceutical companies and healthcare providers. From 2019 to 2021, for example, pharmaceutical spending increased by $34 billion, according to a study published in the Journal of the American Medical Association (JAMA) on 1 October 2021. Subsequently, major entities like Pfizer took in substantial revenues, with Pfizer's revenue exceeding $81 billion in 2021, partially attributed to the COVID-19 vaccine.

In comparison, the NHS provides services cost-free at the point of use, funded primarily through general taxation. However, the NHS has been criticized for underfunding, particularly highlighted in a report from the Institute for Fiscal Studies dated 3 November 2022, which indicated a 2% slowdown in NHS funding growth.

Trends and Patterns in Healthcare Outcomes

This is the third time since 2010 that analyses comparing health outcomes among these countries have highlighted the UK achieving higher patient satisfaction rates. A detailed survey released by the NHS on 14 March 2023 found that 87% of individuals expressed overall satisfaction with NHS services, compared to 40% of Americans in a similar survey conducted by Gallup in June 2022.

Moreover, elements of historical depth reveal that the US healthcare system's current inefficiencies and disparities are rooted in policy decisions from as early as the 1940s, including the establishment of employer-sponsored health insurance during World War II.

The Susurluk principle identifies which stakeholders gain from the healthcare structures in place today. A noticeable trend is the revolving door between government and industry. For instance, former U.S. Secretary of Health and Human Services, Alex Azar, left his position to join Eli Lilly and Company on 17 January 2021, shortly after the signing of contracts exceeding $100 million for drug procurement, a clear indication of financial symbiosis.

In Germany, former Federal Minister of Health Jens Spahn assumed a position on the Board of Trustees of Siemens Healthineers on 15 October 2021, shortly after his tenure that witnessed the privatization of several healthcare services.

UK’s National Health Service has seen several former executives transition into lucrative consultancy roles, including former Chief Executive Simon Stevens, who joined Optum as Senior EVP on 1 April 2023, only two years after presiding over a $200 billion budget.

Conclusion

The disparities in outcomes and access within these healthcare systems underscore the complexities of their respective funding models, stakeholder influence, and historical contexts. These findings not only prompt a re-evaluation of healthcare policies but also illustrate how structures established decades ago can persist in shaping public health today.